ALBILA Inc. was established on January 31, 2017 with a "Angel Investments" project. Shareholder structure of ALBILA has leading business women and businessmen of Turkey's from a total of 40 people. It was founded on a 7-acre area in Eskişehir Industrial Zone, ALBİLA is the first pharmaceutical production facility in Eskişehir, which plans to produce horse-derived antisera against animal stings without damaging the ecosystem.
ALBILA conducts R&D studies with Eskişehir Osmangazi University within the scope of University-Industry cooperation and provides academic support from international universities. The facility, which consists of 1600 square meters R&D, P&D and clean rooms; has a young and dynamic team of chemists, molecular biologists and pharmacists.
ALBILA Headquarters is located in Istanbul and GMP standards production facility located in Eskişehir Organized Industrial Zone; scorpion venom production unit within Osmangazi University; and also there is a horse care and immunization unit in Mahmudiye.